PARIS–(BUSINESS WIRE)–Assured Guaranty (Europe) SA (AGE)*, an indirect subsidiary of Assured Guaranty Ltd. (together with its subsidiaries, Assured Guaranty), announced that it has guaranteed principal and interest payments on €200 million of debt instruments for Autoroute de Liaison Seine-Sarthe Corporate (“ALiS”), an entity owned by a consortium of financial sponsors including Aberdeen, CVC, PGGM and …
BEAUFORT, S.C.–(BUSINESS WIRE)–Optimal Transit, the maritime technology partnership of InMar Technologies and OptiFuel Systems, today announced the Blue Economy VITAL 100 MW Kraaken™ – a second configuration of its Kraaken™ platform that redirects a portion of the vessel’s total power capacity away from data center operations and toward direct utility service: baseload electricity and fresh …
SAN JOSE, Calif. & TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People’s Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology’s operating …
Continue reading “Align Technology Prevails in China Patent Infringement Action Against Angelalign”
BELLEVUE, Wash.–(BUSINESS WIRE)–Savers Value Village, Inc. (the “Company”) (NYSE: SVV), the largest for-profit thrift operator in the United States (“U.S.”) and Canada for value priced pre-owned clothing, accessories and household goods, today announced the pricing and upsize of the previously announced public offering (the “Offering”) of 20,000,000 shares of common stock, par value $0.000001, of …
LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc (“Silence” or the “Company”) , a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has priced its previously announced underwritten public offering of 12,962,963 American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in …
SAN DIEGO–(BUSINESS WIRE)–$ALAR #Alarum—Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Alarum Technologies Ltd. (NASDAQ: ALAR) securities between March 20, 2025 and July 2, 2026 (the “Class Period”). Alarum contends to be global provider of web data collection solutions, …
Under the DARPA It’s About Time program, IonQ will accelerate production and deliver 125 Evergreen-05 optical atomic clocks to U.S. government customers KEY HIGHLIGHTS IonQ has received a $28 million contract extension through DARPA’s It’s About Time program. The company will invest $15 million in dedicated production space, manufacturing equipment, testing capabilities and support staff. …
Continue reading “DARPA Selects IonQ to Produce Next-Generation Atomic Clocks”
Award expands company’s national security portfolio and reinforces its role as a trusted provider of commercial SAR imagery and data services for U.S. government missions COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the world’s leading quantum platform company, today announced that Capella, an IonQ company, has been awarded a contract under the National Reconnaissance Office’s (NRO) …
Continue reading “IonQ’s Space Division Awarded NRO Radar Commercial Augmentation Contract”
Acquisition of 5 operational modern logistic and cold storage assets across Greater Jakarta and Surabaya Marks I Squared’s entry into one of Southeast Asia’s fastest-growing logistics markets MIAMI & SINGAPORE–(BUSINESS WIRE)–I Squared Capital (“I Squared”), a leading independent global infrastructure investor, today announced it has entered into a definitive agreement to acquire Cella (“Cella” or …
SAN DIEGO–(BUSINESS WIRE)–$SPRY #Health—Robbins LLP informs shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the “Class Period”). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization …